Literature DB >> 26868026

Common Variable Immunodeficiency.

Biman Saikia1, Sudhir Gupta2.   

Abstract

Common variable immunodeficiency (CVID) is the most common primary immunodeficiency of young adolescents and adults which also affects the children. The disease remains largely under-diagnosed in India and Southeast Asian countries. Although in majority of cases it is sporadic, disease may be inherited in a autosomal recessive pattern and rarely, in autosomal dominant pattern. Patients, in addition to frequent sino-pulmonary infections, are also susceptible to various autoimmune diseases and malignancy, predominantly lymphoma and leukemia. Other characteristic lesions include lymphocytic and granulomatous interstitial lung disease, and nodular lymphoid hyperplasia of gut. Diagnosis requires reduced levels of at least two immunoglobulin isotypes: IgG with IgA and/or IgM and impaired specific antibody response to vaccines. A number of gene mutations have been described in CVID; however, these genetic alterations account for less than 20% of cases of CVID. Flow cytometry aptly demonstrates a disturbed B cell homeostasis with reduced or absent memory B cells and increased CD21(low) B cells and transitional B cell populations. Approximately one-third of patients with CVID also display T cell functional defects. Immunoglobulin therapy remains the mainstay of treatment. Immunologists and other clinicians in India and other South East Asian countries need to be aware of CVID so that early diagnosis can be made, as currently, majority of these patients still go undiagnosed.

Entities:  

Keywords:  Autoimmunity; Clinical manifestations; Common variable immunodeficiency; Immunological changes

Mesh:

Year:  2016        PMID: 26868026     DOI: 10.1007/s12098-016-2038-x

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  45 in total

1.  Up-regulation of IL-12 in monocytes: a fundamental defect in common variable immunodeficiency.

Authors:  R Cambronero; W A Sewell; M E North; A D Webster; J Farrant
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

2.  Soluble CD26 and CD30 levels in patients with common variable immunodeficiency.

Authors:  M Mahmoudi; M Hedayat; A Aghamohammadi; N Rezaei
Journal:  J Investig Allergol Clin Immunol       Date:  2013       Impact factor: 4.333

3.  [Malignancies in adult patients with common variable immunodeficiency].

Authors:  Eunice López-Rocha; Karen Rodríguez-Mireles; Nora Hilda Segura-Méndez; Marco Antonio Yamazaki-Nakashimada
Journal:  Rev Alerg Mex       Date:  2015 Jan-Mar

4.  Non-Hodgkin lymphoma in pediatric patients with common variable immunodeficiency.

Authors:  Monica Piquer Gibert; Laia Alsina; María Teresa Giner Muñoz; Ofelia Cruz Martínez; Karen Ruiz Echevarria; Olga Dominguez; Ana María Plaza Martín; Juan I Arostegui; Guillem de Valles; Manel Juan Otero; Maria Anunciacion Martin-Mateos
Journal:  Eur J Pediatr       Date:  2015-03-10       Impact factor: 3.183

5.  Classification of common variable immunodeficiencies using flow cytometry and a memory B-cell functionality assay.

Authors:  Amelia L Rösel; Carmen Scheibenbogen; Ulrike Schliesser; André Sollwedel; Bodo Hoffmeister; Leif Hanitsch; Horst von Bernuth; Renate Krüger; Klaus Warnatz; Hans-Dieter Volk; Sybill Thomas
Journal:  J Allergy Clin Immunol       Date:  2014-08-10       Impact factor: 10.793

6.  Flowcytometric phenotyping of common variable immunodeficiency.

Authors:  Klaus Warnatz; Michael Schlesier
Journal:  Cytometry B Clin Cytom       Date:  2008-09       Impact factor: 3.058

7.  Regulatory B cells in CVID patients fail to suppress multifunctional IFN-γ+ TNF-α+ CD4+ T cells differentiation.

Authors:  Marcela Vlkova; Olga Ticha; Jana Nechvatalova; Tomas Kalina; Jiri Litzman; Claudia Mauri; Paul A Blair
Journal:  Clin Immunol       Date:  2015-07-29       Impact factor: 3.969

8.  Non-Hodgkin lymphoma in common variable immunodeficiency.

Authors:  C Cunningham-Rundles; P Lieberman; G Hellman; R S Chaganti
Journal:  Am J Hematol       Date:  1991-06       Impact factor: 10.047

9.  A Clinical and Laboratory Approach to the Evaluation of Innate Immunity in Pediatric CVID Patients.

Authors:  Necil Kutukculer; Elif Azarsiz; Neslihan Edeer Karaca; Ezgi Ulusoy; Guldane Koturoglu; Guzide Aksu
Journal:  Front Immunol       Date:  2015-04-27       Impact factor: 7.561

10.  Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency.

Authors:  Isabella Quinti; Annarosa Soresina; Giuseppe Spadaro; Silvana Martino; Simona Donnanno; Carlo Agostini; Pignata Claudio; Dammacco Franco; Anna Maria Pesce; Federica Borghese; Andrea Guerra; Roberto Rondelli; Alessandro Plebani
Journal:  J Clin Immunol       Date:  2007-02-14       Impact factor: 8.542

View more
  11 in total

1.  Common Variable Immunodeficiency-Associated Inflammatory Enteropathy: The New Era of Biological Therapy.

Authors:  Cátia Arieira; Francisca Dias de Castro; Maria João Moreira; José Cotter
Journal:  GE Port J Gastroenterol       Date:  2018-02-13

2.  Intravenous immunoglobulin replacement treatment reduces in vivo elastase secretion in patients with common variable immune disorders.

Authors:  Alessandro Prezzo; Filomena M Cavaliere; Cinzia Milito; Caterina Bilotta; Metello Iacobini; Isabella Quinti
Journal:  Blood Transfus       Date:  2018-07-17       Impact factor: 3.443

3.  Primary Immunodeficiency Diseases: Need for Awareness and Advocacy in India.

Authors:  Surjit Singh; Sudhir Gupta
Journal:  Indian J Pediatr       Date:  2016-02-29       Impact factor: 1.967

Review 4.  Infectious Complications Reporting in Common Variable Immunodeficiency: A Systematic Review and Meta-analysis.

Authors:  Hamed Zainaldain; Fatema Sadaat Rizvi; Hosein Rafiemanesh; Mahla Alizadeh; Mahnaz Jamee; Sara Mohammadi; Fatemeh Kiaee; Hamed Mohammadi; Farhad Babaie; Reza Yazdani; Hassan Abolhassani; Asghar Aghamohammadi; Gholamreza Azizi
Journal:  Oman Med J       Date:  2020-07-30

Review 5.  Flow Cytometry for Diagnosis of Primary Immune Deficiencies-A Tertiary Center Experience From North India.

Authors:  Amit Rawat; Kanika Arora; Jitendra Shandilya; Pandiarajan Vignesh; Deepti Suri; Gurjit Kaur; Rashmi Rikhi; Vibhu Joshi; Jhumki Das; Babu Mathew; Surjit Singh
Journal:  Front Immunol       Date:  2019-09-11       Impact factor: 7.561

Review 6.  Primary Humoral Immune Deficiencies: Overlooked Mimickers of Chronic Immune-Mediated Gastrointestinal Diseases in Adults.

Authors:  Ida Judyta Malesza; Michał Malesza; Iwona Krela-Kaźmierczak; Aleksandra Zielińska; Eliana B Souto; Agnieszka Dobrowolska; Piotr Eder
Journal:  Int J Mol Sci       Date:  2020-07-23       Impact factor: 5.923

7.  Phenotypically defined subpopulations of circulating follicular helper T cells in common variable immunodeficiency.

Authors:  Sait Yesillik; Sudhir Gupta
Journal:  Immun Inflamm Dis       Date:  2020-07-02

8.  The Diagnosis of Common Variable Immunodeficiency After Multisystem Dysfunction.

Authors:  Taha F Rasul; Daniel R Bergholz; Arfa Faiz
Journal:  Cureus       Date:  2022-01-26

9.  Evaluating the Genetics of Common Variable Immunodeficiency: Monogenetic Model and Beyond.

Authors:  Guillem de Valles-Ibáñez; Ana Esteve-Solé; Mònica Piquer; E Azucena González-Navarro; Jessica Hernandez-Rodriguez; Hafid Laayouni; Eva González-Roca; Ana María Plaza-Martin; Ángela Deyà-Martínez; Andrea Martín-Nalda; Mónica Martínez-Gallo; Marina García-Prat; Lucía Del Pino-Molina; Ivón Cuscó; Marta Codina-Solà; Laura Batlle-Masó; Manuel Solís-Moruno; Tomàs Marquès-Bonet; Elena Bosch; Eduardo López-Granados; Juan Ignacio Aróstegui; Pere Soler-Palacín; Roger Colobran; Jordi Yagüe; Laia Alsina; Manel Juan; Ferran Casals
Journal:  Front Immunol       Date:  2018-05-14       Impact factor: 7.561

Review 10.  Involvement of miR-142 and miR-155 in Non-Infectious Complications of CVID.

Authors:  Giuliana Amato; Federica Vita; Paolina Quattrocchi; Paola Lucia Minciullo; Giovanni Pioggia; Sebastiano Gangemi
Journal:  Molecules       Date:  2020-10-16       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.